363 related articles for article (PubMed ID: 27714988)
1. Intranasal delivery of Natesto® testosterone gel and its effects on doping markers.
Miller GD; Nair V; Morrison MS; Summers M; Willick SE; Eichner D
Drug Test Anal; 2016 Nov; 8(11-12):1197-1203. PubMed ID: 27714988
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of two glucuronides resistant to enzymatic hydrolysis as markers of testosterone oral administration.
Kotronoulas A; Gomez-Gomez A; Segura J; Ventura R; Joglar J; Pozo OJ
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):212-218. PubMed ID: 27328448
[TBL] [Abstract][Full Text] [Related]
3. Drug testing data from the 2007 Pan American Games: delta13C values of urinary androsterone, etiocholanolone and androstanediols determined by GC/C/IRMS.
Aguilera R; Chapman TE; Pereira H; Oliveira GC; Illanes RP; Fernandes TF; Azevedo DA; Neto FA
J Steroid Biochem Mol Biol; 2009 Jul; 115(3-5):107-14. PubMed ID: 19428237
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism.
Strahm E; Mullen JE; Gårevik N; Ericsson M; Schulze JJ; Rane A; Ekström L
Drug Test Anal; 2015; 7(11-12):1063-70. PubMed ID: 26198073
[TBL] [Abstract][Full Text] [Related]
5. Metabolic and isotopic signature of short-term DHEA administration in women: Comparison with findings in men.
Buisson C; Frelat C; Privat K; Martinat N; Audran M; Collomp K
Drug Test Anal; 2018 Nov; 10(11-12):1744-1754. PubMed ID: 30315670
[TBL] [Abstract][Full Text] [Related]
6. Changes in blood parameters after intramuscular testosterone ester injections - Implications for anti-doping.
Solheim SA; Mørkeberg J; Dehnes Y; Hullstein I; Juul A; Upners EN; Nordsborg NB
Drug Test Anal; 2020 Aug; 12(8):1019-1030. PubMed ID: 32307878
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of doping biomarkers after administration of a single dose testosterone gel.
Mullen J; Börjesson A; Hopcraft O; Schulze JJ; Ericsson M; Rane A; Lehtihet M; Ekström L
Drug Test Anal; 2018 May; 10(5):839-848. PubMed ID: 29150907
[TBL] [Abstract][Full Text] [Related]
8. Optimization of an online heart-cutting multidimensional gas chromatography clean-up step for isotopic ratio mass spectrometry and simultaneous quadrupole mass spectrometry measurements of endogenous anabolic steroid in urine.
Casilli A; Piper T; de Oliveira FA; Padilha MC; Pereira HM; Thevis M; de Aquino Neto FR
Drug Test Anal; 2016 Nov; 8(11-12):1204-1211. PubMed ID: 27739243
[TBL] [Abstract][Full Text] [Related]
9. Urinary steroid profile in females - the impact of menstrual cycle and emergency contraceptives.
Mullen JE; Thörngren JO; Schulze JJ; Ericsson M; Gårevik N; Lehtihet M; Ekström L
Drug Test Anal; 2017 Jul; 9(7):1034-1042. PubMed ID: 27758048
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal evaluation of the isotope ratio mass spectrometric data: towards the 'isotopic module' of the athlete biological passport?
Jardines D; Botrè F; Colamonici C; Curcio D; Procida G; de la Torre X
Drug Test Anal; 2016 Nov; 8(11-12):1212-1221. PubMed ID: 27732769
[TBL] [Abstract][Full Text] [Related]
11. Development of a GC/C/IRMS method--confirmation of a novel steroid profiling approach in doping control.
Van Renterghem P; Polet M; Brooker L; Van Gansbeke W; Van Eenoo P
Steroids; 2012 Sep; 77(11):1050-60. PubMed ID: 22728892
[TBL] [Abstract][Full Text] [Related]
12. Influences of musk administration on the doping test.
He Y; Wang J; Liu X; Xu Y; He Z
Steroids; 2013 Nov; 78(11):1047-52. PubMed ID: 23891647
[TBL] [Abstract][Full Text] [Related]
13. Sensitive detection of testosterone and testosterone prohormone administrations based on urinary concentrations and carbon isotope ratios of androsterone and etiocholanolone.
Piper T; Haenelt N; Fusshöller G; Geyer H; Thevis M
Drug Test Anal; 2021 Nov; 13(11-12):1835-1851. PubMed ID: 34648228
[TBL] [Abstract][Full Text] [Related]
14. Detection of synthetic testosterone use by novel comprehensive two-dimensional gas chromatography combustion-isotope ratio mass spectrometry.
Tobias HJ; Zhang Y; Auchus RJ; Brenna JT
Anal Chem; 2011 Sep; 83(18):7158-65. PubMed ID: 21846122
[TBL] [Abstract][Full Text] [Related]
15. Genotype-dependent metabolism of exogenous testosterone - new biomarkers result in prolonged detectability.
Piper T; Schänzer W; Thevis M
Drug Test Anal; 2016 Nov; 8(11-12):1163-1173. PubMed ID: 27649524
[TBL] [Abstract][Full Text] [Related]
16. Profiling of urinary steroids by gas chromatography-mass spectrometry detection and confirmation of androstenedione administration using isotope ratio mass spectrometry.
Wang J; Wu M; Liu X; Xu Y
Steroids; 2011 Dec; 76(14):1560-5. PubMed ID: 21945895
[TBL] [Abstract][Full Text] [Related]
17. Significant increase of salivary testosterone levels after single therapeutic transdermal administration of testosterone: suitability as a potential screening parameter in doping control.
Thieme D; Rautenberg C; Grosse J; Schoenfelder M
Drug Test Anal; 2013; 5(11-12):819-25. PubMed ID: 24167110
[TBL] [Abstract][Full Text] [Related]
18. Carbon isotope ratio mass spectrometry for detection of endogenous steroid use: a testing strategy.
Ahrens BD; Butch AW
Drug Test Anal; 2013 Jul; 5(7):534-40. PubMed ID: 23303562
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of longitudinal steroid profiling with the ADAMS adaptive model for detection of transdermal, intramuscular, and subcutaneous testosterone administration.
Nair VS; Husk J; Miller GD; van Eenoo P; Crouch A; Eichner D
Drug Test Anal; 2020 Oct; 12(10):1419-1431. PubMed ID: 32578357
[TBL] [Abstract][Full Text] [Related]
20. Fast IRMS screening of pseudoendogenous steroids in doping analyses.
de la Torre X; Colamonici C; Curcio D; Botrè F
Drug Test Anal; 2017 Nov; 9(11-12):1804-1812. PubMed ID: 29032611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
